# Jeffrey Kim

> Jeffrey Kim, also known professionally as Jeff Kim, is a scientist and entrepreneur who co-founded Slingshot Biosciences and Radiant Genomics. He led Slingshot as CEO before becoming a senior advisor and board director in May 2025. His career spans molecular biology, biochemistry, industrial biotechnology and a parallel involvement in music and New York’s artist community.

- **Role:** Founder and Board Director at Slingshot Biosciences
- **Organizations:** Slingshot Biosciences, Radiant Genomics, Amyris, Lawrence Berkeley National Laboratory, Pattern Ag, Princeton University, The Rockefeller University
- **Education:** Bachelor’s degree in Molecular Biology, Princeton University, PhD in Biochemistry, The Rockefeller University
- **Known for:** Co-founded Slingshot Biosciences and led development of its core cell-mimic technologies., Co-founded Radiant Genomics, whose acquisition by Zymergen was announced in January 2018., Named co-inventor on hydrogel-particle patents and applications with tunable optical properties.

## Career timeline

- **After Princeton** — Pursued music in New York while working as a research associate in Tarun Kapoor’s laboratory at Rockefeller University.
- **2007–2010** — Doctoral work at Rockefeller University, including research in Sean Brady’s laboratory.
- **2010–2012** — Worked at Amyris, including leading jet fuel development.
- **2012** — Co-founded Radiant Genomics with Oliver Liu and co-founded Slingshot Biosciences.
- **2018-01** — Zymergen announced its acquisition of Radiant Genomics on January 8. Zymergen’s later SEC prospectus dates the underlying acquisition to December 2017.
- **2020** — Slingshot launched its first product suite after years of platform and manufacturing development.
- **2021-07** — Slingshot announced a $23 million Series A led by Northpond Ventures, with ARCH Venture Partners and Anterra Capital participating.
- **2025-05** — Glenn Bilawsky succeeded Kim as Slingshot CEO; Kim continued as senior advisor and board director.
- **2026-10** — Slingshot’s official leadership page lists Kim as Founder, Board Director.

## Achievements

- Co-founded Slingshot Biosciences and led development of its core cell-mimic technologies.
- Co-founded Radiant Genomics, whose acquisition by Zymergen was announced in January 2018.
- Named co-inventor on hydrogel-particle patents and applications with tunable optical properties.
- Led Slingshot through the launch of its first product suite in 2020 and its announced $23 million Series A in July 2021.

## Latest updates

- **2025-05** — Moved from Slingshot CEO to senior advisor and board director.
- **2026-10** — Verified that the official Slingshot leadership page continues to list him as Founder, Board Director.

## Links

- LinkedIn: https://www.linkedin.com/in/kimjeff/

---

Profile page: https://yespress.io/jeffrey-kim
Published by YesPress — https://yespress.io
Last updated: 2026-10-22